Similar to DCN, RLX expression also promoted ECM degradation in the tumor microenvironment to improve therapeutic spread, immune cell accessibility, or macrophage polarization toward antitumor immune response (Yoon et al. 2024; Chang et al. 2021 Kim et al. 2006; Zhou et al. 2021). This evidence concerns the gene DCN and neoplasm.